Differences in SARS-CoV-2 infections during the first and second wave of SARS-CoV-2 between six ethnic groups in Amsterdam, the Netherlands: A population-based longitudinal serological studyLiza Coyer, Maria Prins, Karien Stronks et al.|The Lancet Regional Health - Europe|2021Cited by 49
Health-related quality of life among persons with initial mild, moderate, and severe or critical COVID-19 at 1 and 12 months after infection: a prospective cohort studyAnouk Verveen, Neeltje A. Kootstra, Elke Wynberg et al.|BMC Medicine|2022Cited by 37
A single mRNA vaccine dose in COVID-19 patients boosts neutralizing antibodies against SARS-CoV-2 and variants of concernMarit J. van Gils, Leeann Storey, Hugo D.G. van Willigen et al.|Cell Reports Medicine|2021Cited by 26
SARS-CoV-2 antibody prevalence and correlates of six ethnic groups living in Amsterdam, the Netherlands: a population-based cross-sectional study, June–October 2020Liza Coyer, Maria Prins, Anders Boyd et al.|BMJ Open|2022Cited by 22
SARS-CoV-2 antibody prevalence and determinants of six ethnic groups living in Amsterdam, the Netherlands: a population-based cross-sectional study, June-October 2020Liza Coyer, Maria Prins, Anders Boyd et al.|medRxiv|2021Cited by 12